Association for Research in Vision and Ophthalmology (ARVO) 2024

Long-term efficacy and safety of pegcetacoplan over 36 months: results from 12 months of the GALE open-label extension study

Access Resources

SD-OCT and Fundus Autofluorescence in geographic atrophy: a comprehensive point-to-point correlation of FAF and SD-OCT using the phase III DERBY and OAKS trials

Access Resources

Variability of perilesional FAF patterns associated with automated OCT-based PR/RPE loss ratios in GA progression in the phase 3 OAKS/DERBY trials

Access Resources

Contrast sensitivity function using a prototype gaze tracking-based virtual reality headset in age-related macular degeneration

Access Resources

Prevalence of outer retinal tubulation (ORT) and association with geographic atrophy (GA) lesion growth among GA patients in the OAKS and DERBY trials

Access Resources

A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperimetry at 24 months in OAKS trial

Access Resources

AI-based qOCT analysis of phase-III trials OAKS & DERBY data on the effect of pegcetacoplan on geographic atrophy

Access Resources

Loss of independence in geographic atrophy: results from the MOSAIC study among patients and their caregivers in Europe, Canada, and Australia

Access Resources

Deep learning based segmentation of geographic atrophy in fundus autofluorescence: external validation in imaging acquired in a clinical trial

Access Resources

Pegcetacoplan vs avacincaptad pegol in geographic atrophy: an anchored matching-adjusted indirect comparison of three phase 3 trials

Access Resources

Rate of response to treatment in eyes with GA treated with Pegcetacoplan in a within-patient comparison using automated AI-based OCT biomarker quantifications in OAKS and DERBY

Access Resources

IRIS® Registry analysis of anti-VEGF treatment in patients with coexisting neovascular age-related macular degeneration and geographic atrophy

Access Resources

Pegcetacoplan delays time to development of central scotoma loss of central macular sensitivity: a microperimetry analysis of the phase 3 OAKS study

Access Resources